Ефектът на Xagrid първоначално е бил тестван върху експериментални модели, преди да бъде изучаван при хора.
The effectiveness of Xagrid has been studied in four clinical studies involving a number of patients with various myeloproliferative diseases (diseases where the bone marrow produces too many cells) including nearly 3,000 patients with ET.